DNA/RNAi vaccines
RPS is in the research and development stage with several vaccines.
Sea Lice
RPS developed two sea lice vaccines based on its proprietary DNA/RNAi technology platform. Trials were performed for efficacy and safety by a third-party research institute (Huntsman Marine Science Centre, New Brunswick). The results are under evaluation. Samples from fish involved in the trial are being examined for gene expression at the Atlantic Veterinary College at the University of Prince Edward Island.
ISAV (Infectious salmon Anemia Virus)
Infectious salmon anaemia (ISA) is a serious disease of farmed Atlantic salmon caused by the aquatic orthomyxovirus infectious salmon anaemia virus (ISAV). ISA was first detected in Norway in 1984 and was characterized by severe anaemia and circulatory disturbances.
In Canada, ISA was first detected in farmed Atlantic salmon in New Brunswick in 1996.
RPS has DNA/RNAi vaccines that have already trialed in vivo and in vitro (RNAi). With successful in vitro result, RPS did an in vivo trial with St. Andrews Biological Station in New Brunswick. The result was encouraging.
